Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophylline (Q44505930)
Jump to navigation
Jump to search
scientific article published in January 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophylline |
scientific article published in January 2003 |
Statements
1 reference
Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophylline (English)
1 reference
Roberto Walter Dal Negro
1 reference
Carlo Pomari
1 reference
Silvia Tognella
1 reference
Claudio Micheletto
1 reference
1 January 2003
1 reference
1 reference
Identifiers
1 reference